Our site uses cookies to make navigation as functional as possible, including "third party" cookies and "profiling cookies" designed to tailor on-line contents to suit the preferences expressed while surfing the internet. Should you wish to receive more information, or deny your consent to some or all cookies,
click here
. If you proceed browsing this website, you will be consenting to the use of all cookies.
More info
ita
eng
Our Group
Innovation & Research
Therapy and Wellness
Menarini News
Values
Careers
Home
Home
Menarini News
News archive
News
News details
News archive
Article details
Menarini partner della 40esima edizione del Premio Ischia
Project for network of pediatricians against child abuse
Fair Play Menarini International Awards
Fair Play Menarini International Awards 2019
Fair Play Menarini International Awards 2018
Gallery
Fair Play Menarini International Awards 2017
Press Release Awards
Fair Play Menarini International Awards 2016
Fair Play Menarini International Awards 2020
The 2016 Children's festival in Florence
100 Years in Florence
Menarini Proud Joy
The 2015 Children's Festival in Florence
100 YEARS WITH PONTORMO
Menarini International Fair Play Awards: Menarini celebrates 100 years in Florenece in the name of fair play
Press Room
Media Contact
Media Contact
Video
EFPIA - We Won't Rest Campaign
MENARINI and FARMINDUSTRIA: together we won't rest
Newsletter Subscribe
News Archive
2009 (3)
2010 (18)
2011 (23)
2012 (24)
2013 (16)
2014 (15)
2015 (12)
2016 (24)
2017 (28)
2018 (23)
2019 (24)
2020 (11)
30 Nov 2009
Irritable Bowel Syndrome - OBIS Study. Otilonium Bromide maintains its efficacy even after treatment
Otilonium bromide, a drug used in the treatment of irritable bowel syndrome, maintains its efficacy up to 10 weeks following administration. The results of the international study OBIS (Otilonium Bromide in Irritable Bow...
Read more
01 Nov 2009
www.mimosa-study.com
Mimosa Project in collaboration with ANT against ovarian cancer http://www.mimosa-study.com
Read more
20 Oct 2009
Menarini is granted European rights to Adenuric®, innovative drug for chronic hyperuricaemia in gout.
Ipsen and Menarini announced today the signature of an agreement under which Ipsen, an innovation-driven international specialty pharmaceutical group, grants Menarini exclusive rights for 41 countries for Adenuric® (febuxosta...
Read more
MENARINI PILLS OF ART
Concession granted by Italian Ministry for Cultural Heritage and Activities
Read more